According to a press release, data from an in-clinic study demonstrated that patients using the company’s MiniMed Paradigm System with Low Glucose Suspend automation experienced a 19% reduction in time spent below the low glucose threshold compared with those using conventional pump therapy.
Medtronic one step closer to Artificial Pancreas
Posted in Artificial Pancreas